0 (232) 454 14 14

Specialist Physician İsmail Güzeliş

Specialist Physician İsmail Güzeliş

Short Biography

Specialist Physician Dr. İsmail Güzeliş works in the field of pathology. The medical degree was awarded by Manisa Celal Bayar Üniversitesi in September 2019. Specialist training in medical pathology was completed at İzmir Kâtip Çelebi Üniversitesi between 2019 and 2024, and doctoral studies in molecular pathology began in 2025.

Education

  • Undergraduate medical education: Manisa Celal Bayar Üniversitesi Faculty of Medicine, 2012–2019. Graduation date: 09.2019.
  • Medical specialist training: İzmir Kâtip Çelebi Üniversitesi Faculty of Medicine, Department of Medical Pathology. Start date: 12.2019. End date: 04.2024.
  • Doctoral studies: İzmir Dokuz Eylül Üniversitesi Institute of Health Sciences, Department of Molecular Pathology. Start date: 09.2025.

Professional Experience

  • İzmir Kâtip Çelebi Üniversitesi Faculty of Medicine, Department of Medical Pathology. Start date: 12.2019. End date: 06.2024.
  • İzmir Buca Seyfi Demirsoy Training and Research Hospital, Medical Pathology Clinic. Start date: 06.2024. End date: 09.2026.
  • İzmir Tınaztepe Üniversitesi Buca Medical Center, Medical Pathology, Assistant Professor. Start date: 09.2026.

Academic Studies and Publications

Articles

  • I. GUZELIS, R. GASIMLI, A. SUBASIOGLU & A. SARI, Clinicopathological and genotypic characteristics of colorectal cancer patients carrying a germline MUTYH mutation, REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2026, 0104-4230, 72, 2, 7, WOS.
  • İ. GÜZELİŞ, M. A. UYAROĞLU & İ. ONUR, A cytohistological correlation: Proliferative breast disease with atypia, Cytojournal, 2025, 0974-5963, 22, YÖK.
  • İ. GÜZELİŞ, B. B. KÜÇÜKZEYBEK, M. G. BULUT, Y. Y. BOZOK & Y. KÜÇÜKZEYBEK, Does SOX-2 expression have a prognostic value in triple-negative breast cancer?, Polish Journal of Pathology, 2025, 1233-9687, 76, YÖK.
  • A. G. D. ÜNLÜ, İ. GÜZELİŞ, D. S. KAHRAMAN, D. AYAZ, U. VAROL & M. DEĞİRMENCİ, Evaluation of Tissue Expression of HMBG1 protein in Patients With Breast Cancer, European Journal of Breast Health, 2025, 2587-0831, YÖK.
  • Y. SÜR, E. Ö. GÜR, F. CENGİZ, A. SUBAŞIOĞLU, İ. GÜZELİŞ, S. DEMİR, A. SARI, M. HACIYANLI & O. N. DİLEK, Lynch syndrome association and clinicopathological features in early-onset colorectal cancers: A single-center retrospective study, World Journal of Clinical Oncology, 2025, 2218-4333, 16, YÖK.
  • İ. GÜZELİŞ, B. B. KÜÇÜKZEYBEK, M. A. UYAROĞLU, M. GÖKOVA, G. SEZGİN & Y. KÜÇÜKZEYBEK, HER2-positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature, Diagnostic Cytopathology, 2024, 8755-1039, 52, YÖK.
  • A. KAHRAMAN, F. DİRİLENOĞLU, İ. GÜZELİŞ & Y. K. ÇETİNOĞLU, Intraoperative pathologic diagnosis of central nervous system lymphomas: A comparison of frozen and permanent section diagnoses, and the significance of preoperative imaging, Annals of Diagnostic Pathology, 2024, 1092-9134, 69, YÖK.
  • N. Ö. ELİYATKIN, İ. GÜZELİŞ, C. TAVUSBAY & M. G. BULUT, Memede Kollizyon Tümörü: Heterolog Komponentli Malign Filloides Tümör ve İnvaziv Meme Karsinomu, Spesifiye Edilemeyen Tip, OSMANGAZİ JOURNAL OF MEDICINE, 2023, 1305-4953, 46, YÖK.
  • A. ÇALLI, G. ISSIN, İ. YILMAZ, D. İNCE, E. TURAL, İ. GÜZELİŞ, R. E. ÇEÇEN, H. N. OLGUN, D. GÖKÇAY & E. ÖZER et al., The association of miR-204 and mir-483 5p expression with clinicopathological features of Wilms tumor: Could this provide foresight?, Japanese Journal of Clinical Oncology, 2023, 1465-3621, 53, YÖK.
  • İ. ÖCAL & İ. GÜZELİŞ, Prognostic Significance of Tumor Budding in Urothelial Carcinomas of the Bladder: Comparison of Two Different Tumor Budding Evaluation Methods, Medical Records, 2022, 2687-4555, 4, YÖK.
  • İ. ÖCAL & İ. GÜZELİŞ, Tumor budding is a valuable prognostic parameter in endometrial carcinomas, Indian Journal of Pathology and Microbiology, 2022, 0377-4929, 65, YÖK.
  • İ. ÖCAL, F. U. DUMAN, Z. A. ÖCAL, F. ÇAKALAĞAOĞLU, M. O. HORASANLI & İ. GÜZELİŞ, Idiopathic Scrotal Calcinosis, Analysis of Epithelial Origin by Immunhistochemical Methods, Southern Clinics of Istanbul Eurasia, 2021, 25870998, YÖK.

Presentations

  • İ. GÜZELİŞ, A. G. DİNİZ ÜNLÜ, Y. ADALI, Ö. ÖZ & T. TURAN, PROSTATE ADENOCARCINOMA GLEASON SCORING: DOES IT DIFFER BETWEEN NEEDLE BIOPSY AND RADICAL PROSTATECTOMY, Oral Presentation, 13. Uluslararası Artemis Bilimsel Araştırmalar Kongresi, 28 Ağustos 2025–30 Ağustos 2025.
  • İ. GÜZELİŞ & F. H. DİLEK, Meme Karsinomunun Gastrointestinal Yola Metastazı: 3 Olguluk Vaka Takdimi, Oral Presentation, 19. Uluslararası Tıp ve Sağlık Bilimleri Araştırmaları Kongresi, 12 Temmuz 2025–13 Temmuz 2025.
  • İ. GÜZELİŞ, A. G. DİNİZ ÜNLÜ, Y. ADALI, G. YAVAŞ & H. ŞİMŞEK, Moleküler Patoloji Çağında Beyin Cerrahi Materyallerinin Histopatolojik Değerlendirilmesi, Oral Presentation, 19. Uluslararası Tıp ve Sağlık Bilimleri Araştırmaları Kongresi, July 12, 2025–July 13, 2025.
  • B. BOLAT KÜÇÜKZEYBEK & İ. GÜZELİŞ, The Prognostic Value of Stromal TumorInfiltrating Lymphocytes in Triple-Negative Breast Cancer with No Prior Neoadjuvant Treatment, Oral Presentation, 6TH INTERNATIONAL MEDICAL CONGRESS OF IZMIR DEMOCRACY UNIVERSITY, December 05, 2024–December 06, 2024.
  • İ. GÜZELİŞ, A. SUBAŞIOĞLU & A. SARI, Clinicopathological characteristics and genotypes of MUTYH mutated colorectal cancer patients in the Turkish population, Poster Presentation, 36th European Congress of Pathology, September 07, 2024–September 11, 2024.
  • İ. GÜZELİŞ, B. BOLAT KÜÇÜKZEYBEK, M. GÜRSOY, Y. YILMAZ BOZOK & Y. KÜÇÜKZEYBEK, Prognostic value of SOX-2 nuclear expression in triple- negative breast cancer, Poster Presentation, 36th European Congress of Pathology, September 07, 2024–September 11, 2024.
  • L. D. GÜLKANAT, İ. E. ÇAKIR, İ. GÜZELİŞ, F. ÇAKALAĞAOĞLU & A. KAHRAMAN, Histopathologic patterns in brain metastases of lung adenocarcinoma: does it affect the survival?, Poster Presentation, 34th European Congress of Pathology, September 03, 2022–September 07, 2022.
  • A. ÇALLI, G. ISSIN, İ. YILMAZ, D. İNCE, E. TURAL, İ. GÜZELİŞ, R. E. ÇEÇEN, H. N. OLGUN, D. GÖKÇAY & E. ÖZER, The association of mir-204 and mir-483 5p expression with clinicopathological features of Wilms tumour: could provide foresight?, Poster Presentation, 34th European Congress of Pathology, September 03, 2022–September 07, 2022.
  • İ. GÜZELİŞ, F. ÇAKALAĞAOĞLU, I. E. SEVIN & B. B. YENEN, WHO 2021 histopathological grading of atypical and anaplastic meningiomas, Poster Presentation, 34th European Congress of Pathology, September 03, 2022–September 07, 2022.
  • İ. GÜZELİŞ, İ. E. ÇAKIR & M. A. UYAROĞLU, A case report: micronodular thymoma with lymphoid stroma, and thymic cysts, Poster Presentation, 33rd European Congress of Pathology, August 29, 2021–August 31, 2021.
  • İ. GÜZELİŞ, S. YİĞİT & A. YILDIZ, An early stage ovarian carcinosarcoma and its association with primary tubal carcinoma, Poster Presentation, 33rd European Congress of Pathology, August 29, 2021–August 31, 2021.

Professional Memberships

  • Agean Pathology Association, 2020.
  • European Society of Pathology, 2020.